HiFiBiO Therapeutics
PrivateLast Round
Grant
Apr 16, 2024
Total Funding Raised
$179.5M
Company Overview
HiFiBiO Therapeutics is a biotechnology company that develops a single-cell analytics platform aimed at harnessing the human immune system to fight cancer and autoimmune disorders through innovative biotherapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HiFiBiO Therapeutics Comparables
Compare HiFiBiO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioInvent International | 78% | |
| DIMA Biotechnology | 73% | |
| AbbVie | 71% | |
HiFiBiO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2024 | ||||
| Series D | Jun 14, 2021 | ||||
| Series C | Aug 28, 2019 | ||||
| Series B | May 16, 2018 | ||||
| Series A | Jan 27, 2017 |
Key People
Founding team and executive leadership
HiFiBiO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series B, Series C |
| Legend Star | Series D |
| IDG Capital | Series D, Series C |
| Nest.Bio | Series B, Series A |
| Mirae Asset | Series D |
| B Capital Group | Series D |
| LYFE Capital | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 14, 2021
$75M round led by Mirae Asset Financial Services.
- Aug 28, 2019
$67M round led by IDG Capital.
HiFiBiO Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HiFiBiO Therapeutics's valuation, stock price, and market status.